Abstract: To eliminate accumulation of air while preventing a decrease in pump efficiency, a pump is provided. The pump includes a rotary shaft, an impeller that is attached to the rotary shaft and that rotates with rotation of the rotary shaft, a casing that surrounds the rotary shaft, a shaft sealing device that seals a gap between the casing and the rotary shaft, and a baffle plate part that is located between the impeller and the shaft sealing device and attached to a rotating body. The baffle plate part extends in a direction that is inclined or orthogonal with respect to a surface orthogonal to an axial direction of the rotary shaft.

Abstract: A film antenna receives a wireless signal transmitted by radio, a relay unit relays the received wireless signal to a television receiver, an LED indicator emits light based on a control signal transmitted from the television receiver, a storage case stores the film antenna, the relay unit and a light emitting unit, and a connection member connects the storage case to the television receiver. In addition, in a state of being connected to the television receiver, in a normal direction to a housing surface having a display unit on a housing of the television receiver, the storage case has a protruding section which further protrudes from the housing surface and stores the film antenna in the protruding section. For example, this disclosure can be applied to a receiving device having a receiving unit which receives the wireless signal.

Abstract: A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a maximum blood drug concentration (Cmax) when administered in a fasted state is 400 ng/mL or less, is disclosed.

Abstract: This disclosure relates to a connection device that can provide a new function for an electronic device. A film antenna receives a wireless signal transmitted by radio, a relay unit relays the received wireless signal to a television receiver, an LED indicator emits light based on a control signal transmitted from the television receiver, a storage case stores the film antenna, the relay unit and a light emitting unit, and a connection member connects the storage case to the television receiver. In addition, in a state of being connected to the television receiver, in a normal direction to a housing surface having a display unit on a housing of the television receiver, the storage case has a protruding section which further protrudes from the housing surface and stores the film antenna in the protruding section. For example, this disclosure can be applied to a receiving device having a receiving unit which receives the wireless signal.

Abstract: A pharmaceutical composition for modified release, comprising (1) (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide, or a pharmaceutically acceptable salt thereof, (2) at least one additive which ensures penetration of water into the pharmaceutical composition and which has a solubility such that the volume of water required for dissolving 1 g of the additive is 10 mL or less, and (3) a hydrogel-forming polymer having an average molecular weight of approximately 100,000 or more, or a viscosity of 12 mPa·s or more at a 5% aqueous solution at 25 C is disclosed.

Abstract: A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a maximum blood drug concentration (Cmax) when administered in a fasted state is 400 ng/mL or less, is disclosed.

Abstract: A pharmaceutical composition for modified release, comprising (1) (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide, or a pharmaceutically acceptable salt thereof, (2) at least one additive which ensures penetration of water into the pharmaceutical composition and which has a solubility such that the volume of water required for dissolving 1 g of the additive is 10 mL or less, and (3) a hydrogel-forming polymer having an average molecular weight of approximately 100,000 or more, or a viscosity of 12 mPa·s or more at a 5% aqueous solution at 25° C. is disclosed.

Abstract: A storage device includes: a first disabling unit configured to output write enable signals without change when at least two write addresses of a plurality of write addresses for which write enable signals are enabled and held by a first holding unit do not match; a second holding unit configured to hold sets of the plurality of write addresses held by the first holding unit and the plurality of write enable signals output by the first disabling unit; a second disabling unit configured to output one write enable signal of the plurality of write enable signals held by the second holding unit without change in a test mode; and a third holding unit configured to write data in accordance with sets of the plurality of write addresses held by the second holding unit and the plurality of write addresses output by the second disabling unit.

Abstract: A storage device includes: a first disabling unit configured to output write enable signals without change when at least two write addresses of a plurality of write addresses for which write enable signals are enabled and held by a first holding unit do not match; a second holding unit configured to hold sets of the plurality of write addresses held by the first holding unit and the plurality of write enable signals output by the first disabling unit; a second disabling unit configured to output one write enable signal of the plurality of write enable signals held by the second holding unit without change in a test mode; and a third holding unit configured to write data in accordance with sets of the plurality of write addresses held by the second holding unit and the plurality of write addresses output by the second disabling unit.

Abstract: The present disclosure relates to a light emitting device that can improve design of emitted light. A communication substrate is provided with an LED indicator which emits light. A light guiding plate has a concave surface portion which is a concave surface to cover the LED indicator, and receives the light from the LED indicator using the concave surface portion. A storage case stores the communication substrate and the light guiding plate in a state where a part of the light guiding plate is exposed. The light guiding plate allows the light from the LED indicator to penetrate to a part of the light guiding plate exposed from the storage case by diffusing the light received using the concave surface portion. For example, the present disclosure is applicable to the light emitting device that emits light using an LED or the like.

Abstract: This disclosure relates to a connection device that can provide a new function for an electronic device. A film antenna receives a wireless signal transmitted by radio, a relay unit relays the received wireless signal to a television receiver, an LED indicator emits light based on a control signal transmitted from the television receiver, a storage case stores the film antenna, the relay unit and a light emitting unit, and a connection member connects the storage case to the television receiver. In addition, in a state of being connected to the television receiver, in a normal direction to a housing surface having a display unit on a housing of the television receiver, the storage case has a protruding section which further protrudes from the housing surface and stores the film antenna in the protruding section. For example, this disclosure can be applied to a receiving device having a receiving unit which receives the wireless signal.

Abstract: The present disclosure relates to a light emitting device that can improve design of emitted light. A communication substrate is provided with an LED indicator which emits light. A light guiding plate has a concave surface portion which is a concave surface to cover the LED indicator, and receives the light from the LED indicator using the concave surface portion. A storage case stores the communication substrate and the light guiding plate in a state where a part of the light guiding plate is exposed. The light guiding plate allows the light from the LED indicator to penetrate to a part of the light guiding plate exposed from the storage case by diffusing the light received using the concave surface portion. For example, the present disclosure is applicable to the light emitting device that emits light using an LED or the like.

Abstract: The present disclosure relates to a light emitting device that can improve design of emitted light. A communication substrate is provided with an LED indicator which emits light. A light guiding plate has a concave surface portion which is a concave surface to cover the LED indicator, and receives the light from the LED indicator using the concave surface portion. A storage case stores the communication substrate and the light guiding plate in a state where a part of the light guiding plate is exposed. The light guiding plate allows the light from the LED indicator to penetrate to a part of the light guiding plate exposed from the storage case by diffusing the light received using the concave surface portion. For example, the present disclosure is applicable to the light emitting device that emits light using an LED or the like.

Abstract: A pharmaceutical composition for modified release, comprising (1) (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide, or a pharmaceutically acceptable salt thereof, (2) at least one additive which ensures penetration of water into the pharmaceutical composition and which has a solubility such that the volume of water required for dissolving 1 g of the additive is 10 mL or less, and (3) a hydrogel-forming polymer having an average molecular weight of approximately 100,000 or more, or a viscosity of 12 mPa·s or more at a 5% aqueous solution at 25° C. is disclosed.

Abstract: A pharmaceutical composition for modified release, comprising (1) (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide, or a pharmaceutically acceptable salt thereof, (2) at least one additive which ensures penetration of water into the pharmaceutical composition and which has a solubility such that the volume of water required for dissolving 1 g of the additive is 10 mL or less, and (3) a hydrogel-forming polymer having an average molecular weight of approximately 100,000 or more, or a viscosity of 12 mPa·s or more at a 5% aqueous solution at 25° C. is disclosed.

Abstract: A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4?-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a maximum blood drug concentration (Cmax) when administered in a fasted state is 400 ng/mL or less, is disclosed.